Atlas Trials

Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)

Clinical trial NCT06891443 · RECRUITING

Trial details

NCT number
NCT06891443
Sponsor
Laboratoires Thea
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Leber Congenital Amaurosis 10BlindnessLeber Congenital AmaurosisSensation DisordersVision DisorderNeurological ManifestationsEye Diseases, HereditaryEye DiseasesEye Disorders CongenitalRetinal Disease
Start date
2025-06-04
Primary completion
2027-11-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.